Study shows new 'driver' to assess cancer patient survival and drug sensitivity

Cancer specialists have long looked at genetic mutations and DNA copy changes to help predict patient survival and drug sensitivity. A study led by The University of Texas MD Anderson Cancer Center has opened up yet another avenue for understanding the biological reasons why some people live longer or respond better to treatment - RNA editing events.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news